Feb 23 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, ...

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...

Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo Nordisk in the obesity drug race. While Novo’s shares have struggled this ...

A one-month, four-dose pen could reduce injector component consumption and assembly cycles, addressing a key constraint that has limited GLP-1 category supply reliability. Consolidation of doses may ...

New car financing is available for under 4% APR for borrowers with high credit scores Written By Written by Staff Senior Editor, Buy Side Miranda Marquit is a staff senior personal finance editor for ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the autoinjector device for AJOVY ® ...

Learn how car loans work and how to find the best one for you Betsy began her career in international finance and it has since grown into a comprehensive approach to journalism as she's been able to ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. An auto equity loan could help pay for necessary expenses, but research your ...